Collection / Ipamorelin
Ipamorelin
Ipamorelin is a pentapeptide ghrelin-receptor agonist studied for growth-hormone release. It offers a distinct receptor pathway for exploring growth-axis signalling alongside GHRH analogues.
Simulation only · No real order or payment.
GH secretagogue pentapeptide (ghrelin-receptor agonist)
Also known as: NNC 26-0161
Cells / animal · AnimalResearch & handling
Not for human or veterinary use. Storage, handling, identity and purity require verified batch documentation. No dosing or treatment advice is provided.
At a glance
Ghrelin receptor
Its secretagogue identity centres on the ghrelin-receptor pathway.
Growth-hormone release
Preclinical research examines GH-release activity and selectivity.
Pathway comparison
A different receptor target makes it useful for comparing secretagogue and GHRH signalling.
Explore the study context and sources below. For laboratory research only.
Studies & context
Studied in rat pituitary cells, rats and swine for the selectivity of growth-hormone release.
Cells / animal · AnimalIpamorelin stimulated growth-hormone release in rat pituitary cells and in rat and swine experiments.
Study limitations
The 1998 study is preclinical, not evidence of muscle, sleep or anti-ageing benefits.
In swine, ACTH and cortisol responses were not significantly different from those following GHRH stimulation.
Study limitations
Selectivity in that model does not establish safety in people or effects of a blend.
Published research is separate from PEPTIVIA identity, content, purity, sterility and batch documentation. No source-supplier report verifies PEPTIVIA material.